Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care.
Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.
CAMBRIDGE, MASSACHUSETTS – January 11, 2022 – Paragonix Technologies, Inc., a leading provider of donor organ preservation and transport systems, announced the first time, combination use of LIVERguard™ and Paragonix SherpaPak® to provide advanced preservation for a heart and liver from the same donor.
Legacy of Hope, an Alabama-based Organ Procurement Organization, supported the first-time clinical use of LIVERguard™ Donor Liver Preservation System, and Paragonix SherpaPak, Cardiac Transport System, to provide advanced cold storage, monitoring, and preservation of these critical organs during transport to the donor recipients.
Legacy of Hope is an invaluable partner in supporting the use of advanced preservation technology utilized by the recovering transplant teams. “Our mission is to shepherd the gift of life to those in need of organ and tissue transplants and we happily direct our efforts towards maximizing this wonderful gift, including supporting our transplant programs and patients through the use of advanced preservation technology”, said Chris Meeks, Executive Director of Legacy of Hope.
“We strive to offer new, innovative technologies to our transplant center partners in order to deliver the best possible outcomes for the patients we serve”, states Meeks. The Legacy of Hope staff received specialized training and, in conjunction with Paragonix staff, supported the clinical use of advanced preservation technology during the organ recovery procedure.
“We are excited to offer and expand our support for transplant patients, clinical teams, OPOs, and donor families,” said Lisa Anderson, Ph.D., CEO of Paragonix Technologies. “We will always strive to help our transplant partners with innovative technologies to deliver every possible advantage. OPOs work hard to recover organs for those in need and we are grateful for their willingness to adopt this innovative technology to improve patient care.”
For more information about the Paragonix SherpaPak® and LIVERguard™, visit paragonixtechnologies.com.
About Legacy of Hope
Legacy of Hope is Alabama’s federally designated, non-profit organ procurement organization that coordinates organ and tissue donation for transplant and research. Founded in 1979, Legacy of Hope is a mission-driven organization that builds broad-reaching alliances to educate people about the importance of organ and tissue donation, and inspire them to become donors. Visit legacyofhope.org for more information or to register to be a donor.
L-322 Rev. 0